Old Web
English
Sign In
Acemap
>
authorDetail
>
Tommaso Lupieri Sinibaldi
Tommaso Lupieri Sinibaldi
Novartis
Ranibizumab
Visual acuity
Medicine
in patient
Visual impairment
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization
2019
Graefes Archive for Clinical and Experimental Ophthalmology
Federico Ricci
Giovanni Staurenghi
Monica Varano
Chiara M. Eandi
Tommaso Lupieri Sinibaldi
Laura Colombo
Marta Bartezaghi
Stefania Bassanini
Show All
Source
Cite
Save
Citations (0)
Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study
2019
British Journal of Ophthalmology
Francesco Bandello
Giovanni Staurenghi
Federico Ricci
Edoardo Midena
Francesco Viola
Tommaso Lupieri Sinibaldi
Laura Colombo
Elena Peruzzi
Stefania Bassanini
Show All
Source
Cite
Save
Citations (0)
1